Aller au contenu principal
Profil bibliographique

Rosa Montero

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

41Publications signalées
584Citations signalées
4Affiliations récentes

Les institutions déclarées

Les domaines associés

Renal Transplantation Outcomes and TreatmentsChronic Kidney Disease and DiabetesDiabetes Treatment and ManagementBlood Pressure and Hypertension StudiesDiabetes Management and Research

Les publications récentes

2025 article OpenAlex

Global Climate Crisis: Are We Addressing This? Environmental Sustainability in the Transplantation UK Group

Rosa Montero, Matthew Welberry Smith, John M. O’Callaghan, Carrie Scuffell et autres

Background: The global climate emergency requires action now. 4-5% of greenhouse gas emissions are from healthcare. Kidney disease, dialysis & organ transplantation all use significant resources generating waste with 2M tonnes/yr from haemodialysis alone. Organ donation saves lives & is financially viable …

gb (code pays fourni par la source)

0 citations Journal of the American Society of Nephrology
Accès ouvert 2025 article OpenAlex

Association of British Clinical Diabetologists and UK Kidney Association Joint Clinical Practice Guidelines for the Pharmacological Management of Hyperglycemia in Adults With Type 2 Diabetes Mellitus and CKD

Janaka Karalliedde, Kieran McCafferty, Peter Winocour, Tahseen A Chowdhury et autres

A growing and significant number of people with diabetes develop chronic kidney disease (CKD), and diabetes-related CKD is a leading cause of end-stage kidney disease (ESKD). People with diabetes and CKD have high morbidity and mortality, predominantly related to cardiovascular disease (CVD). …

gb (code pays fourni par la source)

3 citations Kidney International Reports
Accès ouvert 2025 article OpenAlex

Domiciliary subcutaneous furosemide in patients with CKD and HF: a quality improvement project

Ella Tumelty, Rosa Montero, Ashwin Anenden, Jane Nokes et autres

Hospital admissions to treat fluid overload are common in patients with both heart failure and chronic kidney disease (CKD-HF). This is a population with high levels of frailty. Recurrent hospital admissions are costly to both patients and healthcare systems. We designed a …

gb (code pays fourni par la source)

1 citation BMJ Open Quality
Accès ouvert 2025 article OpenAlex

Healthcare resilience in the climate crisis: Do we have any?

Rosa Montero, Isaac Chung, Mark Wright

The UK is increasingly being affected by unpredictable weather events with flooding, heatwaves and storms impacting on physical and mental health and livelihoods. All of these will become increasingly common as the climate crisis accelerates. Efforts made to reduce greenhouse gas (GHG) …

gb (code pays fourni par la source)

3 citations Future Healthcare Journal
Accès ouvert 2025 article OpenAlex

Finerenone in the management of diabetes kidney disease

Parijat De, May Thin Khine, Andrew Frankel, Gabrielle Goldet et autres

People with type 2 diabetes are at risk of developing progressive diabetic kidney disease (DKD) and end stage kidney failure. Hypertension is a major, reversible risk factor in people with diabetes for development of albuminuria, impaired kidney function, end-stage kidney disease and …

gb (code pays fourni par la source)

7 citations BMC Nephrology
Accès ouvert 2024 article OpenAlex

Current management of chronic kidney disease in type‐2 diabetes—A tiered approach: An overview of the joint Association of British Clinical Diabetologists and UK Kidney Association ( ABCD ‐ UKKA ) guidelines

Indranil Dasgupta, Sagen Zac‐Varghese, Khuram Chaudhry, Kieran McCafferty et autres

A growing and significant number of people with diabetes develop chronic kidney disease (CKD). Diabetes-related CKD is a leading cause of end-stage kidney disease (ESKD) and people with diabetes and CKD have high morbidity and mortality, predominantly related to cardiovascular disease (CVD). …

gb (code pays fourni par la source)

16 citations Diabetic Medicine
2024 article OpenAlex

Urinary Tract Infections in Kidney Transplant Recipients: A Single-Centre Experience

Nicholas Evans, Rosa Montero

Background: Urinary tract infections(UTIs) occur in 25% of kidney transplant recipients (KTR) within one year post-transplant(PTx) accounting for 45% of infective complications. Few reports are on the timeframe of recurrent UTIs >1yrs PTx. Recurrent UTIs are associated with bacteraemias, impaired allograft function, …

gb (code pays fourni par la source)

1 citation Journal of the American Society of Nephrology
2024 article OpenAlex

Fistula Ligation after Kidney Transplant: Yes or No?

Faris Ahmed, Rosa Montero

Background: Cardiovascular disease (CVD) accounts for 30-35% of all-cause mortality in kidney transplant recipients (KTR) causing 25% of deaths 1-year post-transplant. Arteriovenous Fistulas(avf) have been shown to contribute to CVD progression with up to 42% of ESRD patients on dialysis developing Heart …

gb (code pays fourni par la source)

0 citations Journal of the American Society of Nephrology
2024 article OpenAlex

BK Nephropathy Treatments in Kidney Transplant Recipients

Vanessa Morayo Ogungbesan, Dewanshi Maniar, Rosa Montero

Background: BK virus is a polyoma virus(BKPyV) and an important cause of allograft loss in kidney transplant recipients(KTR). Currently there are no effective treatments for BKPyV with centres using combination therapies strategies. It is unclear whether the increase in BK viraemia is …

gb (code pays fourni par la source)

0 citations Journal of the American Society of Nephrology
Accès ouvert 2024 article OpenAlex

Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024

Sagen Zac‐Varghese, Patrick B. Mark, Steve Baín, Debasish Banerjee et autres

The contribution of chronic kidney disease (CKD) towards the risk of developing cardiovascular disease (CVD) is magnified with co-existing type 1 or type 2 diabetes. Lipids are a modifiable risk factor and good lipid management offers improved outcomes for people with diabetic …

gb (code pays fourni par la source)

24 citations BMC Nephrology
Accès ouvert 2024 erratum OpenAlex

Corrigendum to “WCN24-813 MANAGEMENT OF ACUTE FLUID OVERLOAD IN HEART FAILURE PATIENTS WITH CKD USING HOME DELIVERED SUBCUTANEOUS FUROSEMIDE” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Page S251-S252]

Rosa Montero, Ashwin Anenden, Jane Nokes, Vasa Gnanapragasam et autres

The authors regret that the first author’s name, Ella Tumelty1, was missing from the published abstract. The authors would like to apologize for any inconvenience caused. DOI of original article: https://doi.org/10.1016/j.ekir.2024.02.515 WCN24-813 MANAGEMENT OF ACUTE FLUID OVERLOAD IN HEART FAILURE PATIENTS WITH …

gb (code pays fourni par la source)

0 citations Kidney International Reports
Accès ouvert 2024 article OpenAlex

WCN24-813 MANAGEMENT OF ACUTE FLUID OVERLOAD IN HEART FAILURE PATIENTS WITH CKD USING HOME DELIVERED SUBCUTANEOUS FUROSEMIDE

Rosa Montero, Ashwin Anenden, Jane Nokes, Vasa Gnanapragasam et autres

Hospital admissions due to heart failure (HF) are common, even more so in patients who also have chronic kidney disease (CKD). These admissions often require intravenous diuretics to treat fluid accumulation. Patients with concomitant HF and CKD (HF-CKD) have a high risk …

gb (code pays fourni par la source)

0 citations Kidney International Reports

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.